Larotrectinib

Chemical formula: C₂₁H₂₂F₂N₆O₂  Molecular mass: 428.444 g/mol 

Therapeutic indications

Larotrectinib is indicated for:

Solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion

Population group: only adults (18 - 65 years old)

Larotrectinib as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion,

  • who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and
  • who have no satisfactory treatment options.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Larotrectinib as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion,

  • who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and
  • who have no satisfactory treatment options.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: VITRAKVI Hard capsule
Structured Product Labeling (SPL/PLR) 2019: VITRAKVI Capsule / Oral solution
Summary of Product Characteristics (SPC) 2020: VITRAKVI Oral solution
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈